Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
08 Nov 2023 |
On P&L |
The Company releases the press release related to the first nine months of 2023 financial results
|
Download |
|
08 Nov 2023 |
On P&L |
The Company releases the first nine months 2023 financial results presentation
|
Download |
|
26 Jul 2023 |
On P&L |
The Company releases the press release related to the first half 2023 financial results
|
Download |
|
26 Jul 2023 |
On P&L |
The Company releases the first half 2023 financial results presentation
|
Download |
|
26 Jul 2023 |
On buy-back programmes |
The Company reports the commencement, effective as of today, 26 July 2023, of a share buyback program.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
25 Feb 2025 |
Annual Report regarding remuneration of the members of the Board of Directors |
ROVI releases the 2024 annual report regarding remuneration of the members of the Board of Directors
|
Download |
|
07 Jan 2025 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the fourth quarter of 2024
|
Download |
|
07 Nov 2024 |
On P&L |
A correction to the English version of a document is reported.
|
Download |
|
03 Oct 2024 |
Liquidity and counterparty agreements |
Liquidity contract: transactions conducted in the third quarter of 2024
|
Download |
|
12 Sep 2024 |
Other relevant information |
The Company announces the registration in the Commercial Registry of the public deed of reduction of its share capital and the new share capital figure.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017.
|
Download |
|
03 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted from 11 July to 30 September 2017
|
Download |
|
07 Sep 2017 |
Otros sobre negocio y situación financiera |
The Company informs that commences the enoxaparin biosimilar marketing in Germany
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
Pages
